Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients (ACDM-Maccabi)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01101126 |
Recruitment Status
:
Terminated
(An excess of all-cause acute health services utilization in the intervention arm)
First Posted
: April 9, 2010
Last Update Posted
: January 21, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Obstructive Pulmonary Disease (COPD) Asthma | Other: Pulmonary disease management Other: Usual care | Not Applicable |
The aim of the present study is to test the efficacy of a comprehensive community disease management program in patients with unstable chronic obstructive pulmonary disease (COPD) or asthma. The intervention is delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals at the community, in the Jerusalem and the Lowland District of Maccabi Health Services in Israel.
The main purpose is to evaluate the effect of the intervention on the use acute care and emergency health services for acute exacerbation of the lung disease.
Secondary objectives include the evaluation of the effect of the intervention on quality of life, physical function, pulmonary function test, depression and all-cause mortality.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 492 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Disease Management Program for Chronic Obstructive Pulmonary Diseases in Maccabi Health Services |
Study Start Date : | March 2010 |
Actual Primary Completion Date : | March 2013 |
Actual Study Completion Date : | April 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: Disease Management
Comprehensive care delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals in the community
|
Other: Pulmonary disease management
Comprehensive pulmonary care including patient education of self-care, coordination of care, monitoring of patient adherence, providing advice in acute exacerbations
|
Active Comparator: Unual care
Care delivered by the primary practitioner with the advice of a consultant pulmonologist
|
Other: Usual care
Pulmonary disease is managed by the primary practitioner and a consultant pulmonologist
|
- Healthcare services utilization for acute exacerbations of pulmonary disease [ Time Frame: Every 6 months during 1-3 years' follow-up ]The proportion of patients who, due to exacerbation of their COPD or asthma, have at least one out of hours visit to a "off-hour non-hospital based acute-care facilities", or a visit to a hospital emergency room, or a hospitalization within the two years of follow-up.
- Quality of life [ Time Frame: Every 6 months during 1-3 years' follow-up ]Health-related quality of life
- Pulmonary function tests [ Time Frame: Every 6 months during 1-3 years' follow-up ]Pulmonary function tests
- Physical function [ Time Frame: Every 6 months during 1-3 years' follow-up ]6-minutes walk test assessment
- Depression [ Time Frame: Every 6 months during 1-3 years' follow-up ]PHQ-9 Questionnaire

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Men and women
- 40 years or older
- Having unstable COPD or Asthma
Exclusion Criteria:
- Significant LV dysfunction
- Other severe chronic morbidity compromising short-term survival
- Significant cognitive impairment or psychiatric disease
- Bedridden
- Homeless or no telephone connection

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01101126
Israel | |
Maccabi Pulmonary Clinic | |
Bat-Yam, Israel | |
Maccabi Pulmonary Clinic | |
Holon, Israel |
Principal Investigator: | Meir Raz, M.D. | Maccabi Healthcare Services, Israel | |
Study Director: | Ofra Kalter - Leibovici, M.D. | Sheba Medical Center |
Responsible Party: | Ofra Kalter-Leibovici MD, Dr., Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT01101126 History of Changes |
Other Study ID Numbers: |
SHEBA-10-7741-OK-CTIL |
First Posted: | April 9, 2010 Key Record Dates |
Last Update Posted: | January 21, 2015 |
Last Verified: | January 2015 |
Keywords provided by Ofra Kalter-Leibovici MD, Sheba Medical Center:
Chronic obstructive pulmonary disease (COPD) Asthma |
Additional relevant MeSH terms:
Asthma Lung Diseases Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Bronchial Diseases |
Respiratory Tract Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |